Zhonghua yi xue za zhiHumansProlactinomaPituitary NeoplasmsFemale
[The evolving role of surgery in the management of pituitary prolactinomas].
Y F Wang, Z Y Chen
Published: 202510.3760/cma.j.cn112137-20250811-02037
Abstract
Recently, the therapeutic paradigm for pituitary prolactinomas has shifted from a single-pathway of "drug priority" approach toward a multidisciplinary assessment and individualized treatment model. The "Consensus on the diagnosis and treatment of pi…
Preview only. Read the full abstract at the source